Quest Diagnostics SVP Plewman sold 5,662 shares at $204.00 for $1.2M; retains 15,381 shares post-sale.
Patrick Plewman, SVP for Diagnostic Services at Quest Diagnostics, sold 5,662 shares at $204.00 on 2026-02-10, reducing his holdings by 26.9% from 21,043 to 15,381 shares. The sale occurred when the stock was trading 1.2% below its 52-week high of $209.32, and within the context of a 30-day gain of +15.0% and 90-day gain of +10.6%, reflecting significant recent upward price momentum. The transaction represents a substantial reduction in direct shareholdings by a senior executive in diagnostic services at a $23.0B company generating $2.8B quarterly revenue, warranting standard monitoring of insider positioning patterns.